225 related articles for article (PubMed ID: 24272459)
1. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
2. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
[TBL] [Abstract][Full Text] [Related]
3. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
[TBL] [Abstract][Full Text] [Related]
4. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
5. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
6. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors.
Villaseñor A; Ballard-Barbash R; Ambs A; Bernstein L; Baumgartner K; Baumgartner R; Ulrich CM; Hollis BW; McTiernan A; Neuhouser ML
Cancer Causes Control; 2013 Apr; 24(4):759-67. PubMed ID: 23361338
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
[TBL] [Abstract][Full Text] [Related]
9. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
[TBL] [Abstract][Full Text] [Related]
10. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.
Yao S; Kwan ML; Ergas IJ; Roh JM; Cheng TD; Hong CC; McCann SE; Tang L; Davis W; Liu S; Quesenberry CP; Lee MM; Ambrosone CB; Kushi LH
JAMA Oncol; 2017 Mar; 3(3):351-357. PubMed ID: 27832250
[TBL] [Abstract][Full Text] [Related]
11. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
[TBL] [Abstract][Full Text] [Related]
12. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
Hu K; Callen DF; Li J; Zheng H
Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
[TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
[TBL] [Abstract][Full Text] [Related]
14. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.
Zhou W; Heist RS; Liu G; Asomaning K; Neuberg DS; Hollis BW; Wain JC; Lynch TJ; Giovannucci E; Su L; Christiani DC
J Clin Oncol; 2007 Feb; 25(5):479-85. PubMed ID: 17290055
[TBL] [Abstract][Full Text] [Related]
15. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
[TBL] [Abstract][Full Text] [Related]
16. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
17. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.
McCullough ML; Rodriguez C; Diver WR; Feigelson HS; Stevens VL; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2898-904. PubMed ID: 16365007
[TBL] [Abstract][Full Text] [Related]
18. Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study.
Vrieling A; Buck K; Heinz J; Obi N; Benner A; Flesch-Janys D; Chang-Claude J
Breast Cancer Res Treat; 2012 Nov; 136(1):195-207. PubMed ID: 22961011
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
